Serum zinc, chromium, and iron concentrations in dogs with lymphoma and osteosarcoma

Journal of Veterinary Internal Medicine

Volumn 15, Issue 6, 2001, Pages 585-588

  Kazmierski, Kathy J ^a,c   Ogilvie, Gregory K ^a   Fettman, Martin J ^a   Lana, Susan E ^a   Walton, Judy A ^a   Hansen, Rod A ^a   Richardson, Kristi L ^a   Hamar, Dwayne W ^a   Bedwell, Cathy L ^a   Andrews, Gordon ^b   Chavey, Sue ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c USA   (United States)

Author keywords

Glucose tolerance; Hyperinsulinemia; Iron sequestration; Natural killer cells

Indexed keywords

CHROMIUM; IRON; ZINC;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BONE TUMOR; CASE CONTROL STUDY; DOG; DOG DISEASE; FEMALE; GLUCOSE TOLERANCE TEST; HYPERINSULINEMIA; LYMPHOMA; MALE; NATURAL KILLER CELL; NUTRITIONAL DEFICIENCY; OSTEOSARCOMA; PATHOLOGY;

ANIMAL; BONE NEOPLASMS; CASE-CONTROL STUDIES; CHROMIUM; DOG DISEASES; DOGS; FEMALE; GLUCOSE TOLERANCE TEST; HYPERINSULINEMIA; IRON; KILLER CELLS, NATURAL; LYMPHOMA; MALE; OSTEOSARCOMA; SUPPORT, NON-U.S. GOV'T; ZINC;

EID: 0035515612     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2001.tb01595.x     Document Type: Article

References (22)

1. Ogilvie GK, Walters L, Salman MD, et al. Alterations in carbohydrate metabolism in dogs with non-hematopoietic malignancies. Am J Vet Res 1997;58:277-281.
2. Rofe AM, Bourgeois CS, Coyle P, et al. Altered insulin response to glucose in weight-losing cancer patients. Anticancer Res 1994;14:647-650.
3. Prasad AS, Kaplan J, Beck FW, et al. Trace elements in head and neck cancer patients: Zinc status and immunologic functions. Otolaryngol Head Neck Surg 1997;116:624-629.
4. Prasad AS, Beck FWJ, Doerr TD, et al. Nutritional and zinc status of head and neck cancer patients: An interpretive review. J Am Coll Nutr 1998;17:409-418.
5. Jacobs A, Worwood M. Iron in Biochemistry and Medicine. London: Academic Press Inc; 1980.
6. Rouault TA, Klausner RD. The impact of oxidative stress on eukaryotic iron metabolism. EXS 1996;77:183-197 (review).
7. Anderson RA. Chromium in the prevention and control of diabetes. Diabetes Metab 2000;26:22-27 (review).
8. Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr 1998;17:548-555 (review).
9. Doerr TD, Marks SC, Shmsa FH, et al. Effects of zinc and nutritional status on clinical outcomes in head and neck cancer. Nutrition 1998;14:489-495.
10. Cersosimo E, Pisters PW, Pesola G, et al. The effect of graded doses of insulin on peripheral glucose uptake and lactate release in cancer cachexia. Surgery 1991;109:459-467.
11. Weide M, Zhaoming D, Baoliang L, Huibi X. Study of immune function of cancer patients influenced by supplemental zinc or selenium-zinc combination. Biol Trace Elem Res 1991;28:11-20.
12. Ogilvie GK, Fettman MJ, Mallinckrodt CH, et al. Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: A double-blind, randomized placebo-controlled study. Cancer 2000;88:1916-1928.
13. Helrich K. Official Methods of Analysis of the Association of Official Analytical Chemists, 15th ed. Arlington, VA: Association of Official Analytical Chemists, Inc; 1990: AOAC method 974.27, parts A, B, E, and F, and 969.32, part D. 1990.
14. Rothery E. "Cr," Varian Analytical Methods for Graphite Tube Atomizers. Victoria, Australia: Varian Australia Pty Ltd; 1998:43. Publication 85-100848-00.
15. Andrews GA, Weeks BR, Smith JE, et al. An improved ferritin assay for canine sera. Vet Clin Pathol 1992;21:57-60.
16. Westin T, Ahlbom E, Johansson E, et al. Circulating levels of selenium and zinc in relation to nutritional status in patients with head and neck cancer. Otolaryngol Head Neck Surg 1989;115:1079-1082.
17. Kaplan LA, Pesce AJ. Clinical Chemistry: Theory, Analysis, Correlation, 3rd ed. St. Louis, MO: Mosby-Year Book Inc; 1996:697-714.
18. Keyzer JJ, Oosting E, Wolthers BG, et al. Zinc in plasma and serum: Influence of contamination due to the collection tubes. Pharm Weekbl Sci 1983;5:248-251.
19. Tayek JA, Manglik S, Abemayor E. Insulin secretion, glucose production, and insulin sensitivity in underweight and normal-weight volunteers, and in underweight and normal-weight cancer patients: A clinical research center study. Metabolism 1997;46:140-145.
20. Cairo G, Castrusini E, Minotti G, et al. Superoxide and hydrogen peroxide-dependent inhibition of iron regulatory protein activity; a protective stratagem against oxidative injury. FASEB J 1997;10:1326-1335.
21. Miyazawa K, Shiota M, Takakuwa Y, et al. Mechanism of hyperferritinemia in a case of malignant histiocytosis. Nippon Ketsueki Gakkai Azsshi Acta Haematol Japonica 1990;53:575-581 (in Japanese).
22. Newlands CE, Houston DM, Vasconcelos DY. Hyperferritinemia associated with malignant histiocytosis in a dog. JAVMA 1994;205:849-851.